Renal Protection During Impella®-Supported PCI in Patients With High-Risk Complex Coronary Artery Disease

Protected PCI with Impella lowers the incidence of AKI when compared to high-risk PCI in ECMO-supported patients and demonstrates a lower AKI rate than the overall predicted AKI risk in this population. Therefore, Impella-mediated hemodynamic support should be considered as an AKI risk reduction strategy during high-risk PCI in order to allow for more complete revascularization and prevent staging of interventions.